05/02/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
4:19 PM | Matinas Biopharma (Issuer)
Murphy Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
4:19 PM | Jabbour Jerome D (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
4:19 PM | D An Evelyn (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
4:19 PM | Matinas Biopharma (Issuer)
Smith Robin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
4:19 PM | Matinas Biopharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2025
11:15 PM | Matinas Biopharma (Filer)
| Form EFFECT | |
04/29/2025
4:15 PM | Matinas Biopharma (Filer)
| Form ARS | |
04/22/2025
4:28 PM | Matinas Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/15/2025
4:18 PM | Matinas Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/10/2025
8:39 PM | Matinas Biopharma (Issuer)
STERN ADAM K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for MTNB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Matinas Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
04/10/2025
4:14 PM | Matinas Biopharma (Subject)
Sanitam Partners LLC (Filed by)
| Form SCHEDULE 13D/A | |
04/10/2025
3:45 PM | Matinas Biopharma (Issuer)
Sanitam Partners LLC (Reporting)
| Form 4/A | |
04/10/2025
12:54 PM | Matinas Biopharma (Issuer)
Pembroke & Partners LLC (Reporting)
| Form 4/A | |
04/10/2025
12:59 PM | EIDE ROBERT J (Reporting)
Matinas Biopharma (Issuer)
| Form 4/A | |
04/10/2025
12:44 PM | Matinas Biopharma (Subject)
Pembroke & Partners LLC (Filed by)
| Form SCHEDULE 13D/A | |
04/08/2025
4:25 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:15 PM | Matinas Biopharma (Filer)
| Form NT 10-K | |
03/17/2025
4:30 PM | Matinas Biopharma (Issuer)
NEUGEBOREN EDWARD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/17/2025
4:30 PM | Matinas Biopharma (Issuer)
Murphy Keith (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/14/2025
4:20 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
6:01 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
5:35 PM | EIDE ROBERT J (Reporting)
Matinas Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/03/2025
4:25 PM | Matinas Biopharma (Filer)
| Form DEF 14A | |
02/28/2025
3:58 PM | Matinas Biopharma (Issuer)
Sanitam Partners LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2025
5:35 PM | Matinas Biopharma (Issuer)
Pembroke & Partners LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2025
4:15 PM | Matinas Biopharma (Filer)
| Form PRE 14A | |
02/21/2025
2:07 PM | Matinas Biopharma (Subject)
Sanitam Partners LLC (Filed by)
| Form SCHEDULE 13D | |
02/21/2025
2:11 PM | Matinas Biopharma (Subject)
Pembroke & Partners LLC (Filed by)
| Form SCHEDULE 13D | |
02/19/2025
3:05 PM | Matinas Biopharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/19/2025
1:22 PM | 111 Equity Group (Filed by)
Matinas Biopharma (Subject)
| Form SCHEDULE 13D/A | |
02/13/2025
5:00 PM | Matinas Biopharma (Issuer)
Smith Robin L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/13/2025
4:20 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
4:00 PM | D An Evelyn (Reporting)
Matinas Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2025
6:30 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:15 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:16 PM | Matinas Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:31 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:15 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Matinas Biopharma (Subject)
| Form SC 13G | |
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad) A Historic Gold Announcement Is About to Rock Wall Street
For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains. Be ready before the historic gold move. Get Garrett’s Top Four picks now. |
09/03/2024
7:56 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
8:39 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:06 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy MTNB Stock Free MTNB Stock Alerts